Test Code RSPCR2 Influenza A/B, RSV, and SARS-CoV-2, PCR

Additional Codes
EPIC | LAB4608 |
Purpose
The Xpert Xpress CoV-2/Flu/RSV plus test is intended for use in the simultaneous in vitro qualitative detection and differentiation of severe acute respiratory syndrome coronavirus (SARS-CoV-2), influenza A, influenza B, and respiratory syncytial virus (RSV) viral RNA in nasopharyngeal swab specimens collected from individuals with signs and symptoms of respiratory tract infection. Clinical signs and symptoms of respiratory tract infection due to SARS-CoV-2, influenza A/B, and RSV can be similar.
Source: Xpert Xpress CoV-2/Flu/RSV plus IFU 302-8057 , Rev. A September 2023
Methodology
Multiplexed real-time reverse transcriptase polymerase chain reaction (RT-PCR) - Cepheid
Sample Type
***The requirement for 2 swabs is no longer necessary, collect 1 swab per order****
Acceptable Swab Sources | |
---|---|
Nasopharyngeal (NP) | |
Mid-turbinate Nasal |
Acceptable Transport Media | |
---|---|
UTM-RT | M4RT |
NOTE: Swabs must be placed in acceptable transport media at the time of collection!
Specimen Stability
Temperature | Time |
---|---|
Ambient (15-30°C) | 48 hours |
Refrigerated (2-8°C) (store) | 7 days |
Frozen (-20 to -80) |
Specimen stability applies only to swabs in acceptable transport media.
Result Reporting
Target | Result Reporting | Precautions |
---|---|---|
SARS-CoV-2 | Detected | Airborne + Contact |
Not Detected | N/A | |
Influenza A | Detected | Droplet |
Not Detected | N/A | |
Influenza B | Detected | Droplet |
Not Detected | N/A | |
RSV | Detected | Contact + Droplet |
Not Detected | N/A |
Rejection Criteria
- Mislabeled/Unlabeled specimens
- Specimens outside of stability limits
- Specimens collected with unacceptable swab type.
- Specimens submitted without transport media or with unacceptable transport media.
Availability
Performed | STAT |
---|---|
24/7 | Yes |
Performing Laboratory
MultiCare Yakima Memeorial Hospital Laboratory
Lab Department
Microbiology
CPT Code
0241U
LOINC
95941-1 Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel NAA+probe (Respiratory system specimen)